Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESRRA | P11474 | 8/20 | 0.60 |
| ▸ | FOXM1 | Q08050 | 1/20 | 0.59 |
| ▸ | HDAC4 | P56524 | 5/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.55 |
| ▸ | PIM1 | P11309 | 2/20 | 0.53 |
| ▸ | PIM2 | Q9P1W9 | 2/20 | 0.53 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.52 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.52 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.51 |
| ▸ | PPARA | Q07869 | 1/20 | 0.51 |
| ▸ | PPARG | P37231 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6236807 | 1.00 | ESRRA (0.60) | ESRRAFOXM1HDAC4CYP3A4PIM1 | |
| SCHEMBL6497480 | 0.84 | ESRRA (0.61) | ESRRAFOXM1CYP3A4PIM1PIM2 | |
| SCHEMBL6497485 | 0.84 | ESRRA (0.61) | ESRRAFOXM1CYP3A4PIM1PIM2 | |
| SCHEMBL6235536 | 0.84 | ESRRA (0.60) | ESRRAFOXM1CYP3A4PIM1PIM2 | |
| SCHEMBL6235532 | 0.84 | ESRRA (0.60) | ESRRAFOXM1CYP3A4PIM1PIM2 | |
| SCHEMBL6503306 | 0.81 | PPARA (0.61) | HDAC4HDAC8PPARA | |
| SCHEMBL6234267 | 0.79 | PIM1 (0.67) | PIM1PIM2PDE4BPIM3 | |
| SCHEMBL6234271 | 0.79 | PIM1 (0.67) | PIM1PIM2PDE4BPIM3 | |
| SCHEMBL6497637 | 0.79 | ESRRA (0.61) | ESRRAFOXM1CYP3A4PIM1PIM2 | |
| SCHEMBL6497642 | 0.79 | ESRRA (0.61) | ESRRAFOXM1CYP3A4PIM1PIM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1213287-B1 | SUBSTITUTED BENZYLTHIAZOLIDINE-2,4-DIONE DERIVATIVES | KYORIN SEIYAKU KK (JP) | 2005-05-25 | — | — | EP | disclosed |
| US-6730687-B1 | THERAPY OF METABOLIC DISEASES SUCH AS DIABETES AND HYPERLIPIDEMIA AS AGONISTS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 2004-05-04 | — | — | US | disclosed |
| EP-1213287-A1 | SUBSTITUTED BENZYLTHIAZOLIDINE-2,4-DIONE DERIVATIVES | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 2002-06-12 | — | — | EP | disclosed |